NCT01184196

Brief Summary

This study will enroll patients who will be receiving primary total knee replacements. Subjects will be randomized into two groups: Betadine surgical scrub preparation and ChloraPrep preparation prior to total knee replacements. Study hypothesis: When used as a surgical scrub preparation prior to primary total knee arthroplasties, ChloraPrep (2% chlorhexadine gluconate and 70% isopropyl alcohol) is superior to Betadine (10% povidone iodine) in reducing incision site bacterial colony counts.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2009

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 18, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

April 16, 2013

Status Verified

April 1, 2013

Enrollment Period

3.1 years

First QC Date

August 16, 2010

Last Update Submit

April 15, 2013

Conditions

Keywords

knee replacementknee arthroplastytotal knee replacementarthroplasty, knee replacement

Outcome Measures

Primary Outcomes (1)

  • Quantitative bacterial colony counts for aerobic and anaerobic culture swabs will be taken at 3 timeperiods to determine if ChloraPrep is superior to Betadine in reducing incision site bacterial colony counts.

    Subjects scheduled to undergo primary total knee arthroplasty will be randomized to receive either a Betadine surgical scrub or ChloraPrep surgical scrub at the time of surgery. Subjects will be enrolled until swab #3 is obtained, 24 hours post-surgery.

    24 hours

Study Arms (2)

Arm 1

ACTIVE COMPARATOR

Subjects randomized to Arm 1 will receive Betadine surgical scrub at the time of primary total knee arthroplasty.

Drug: Swab area with Betadine

Arm 2

ACTIVE COMPARATOR

Subjects in Arm 2 will receive ChloraPrep surgical scrub prior to elective primary total knee arthroplasty.

Drug: Swab area with ChloraPrep

Interventions

A swab will be taken over the operative knee before surgical site preparation is started, after preparation has taken place, and 24 hours post-surgery.

Also known as: Povidone Iodine
Arm 1

A swab will be taken over the operative knee before surgical site preparation is started, after preparation has taken place, and 24 hours post-surgery.

Also known as: Chlorhexadine Gluconate
Arm 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled to undergo primary total knee arthroplasty
  • Age 18 or over

You may not qualify if:

  • Inability to provide informed consent or to comply with study assessments due to cognitive impairment or geographic distance
  • Age 17 or younger
  • Allergies to chlorhexadine gluconate or povidone iodine
  • Topical antimicrobial use within 14 days of surgery
  • Any active dermatoses or open wounds over the operative site
  • Any condition requiring antibiotics 14 days prior to arriving for surgery
  • Patients with chronic immunosuppression (such as HIV/AIDS)
  • Unable to adhere to follow up schedule and treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central DuPage Hospital

Winfield, Illinois, 60190, United States

Location

Related Publications (8)

  • Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005 May;87(5):980-5. doi: 10.2106/JBJS.D.01977.

    PMID: 15866959BACKGROUND
  • Edwards PS, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev. 2004;(3):CD003949. doi: 10.1002/14651858.CD003949.pub2.

    PMID: 15266508BACKGROUND
  • Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control. 1988 Aug;16(4):173-7. doi: 10.1016/0196-6553(88)90029-6.

    PMID: 3189943BACKGROUND
  • Kaul AF, Jewett JF. Agents and techniques for disinfection of the skin. Surg Gynecol Obstet. 1981 May;152(5):677-85. No abstract available.

    PMID: 7013126BACKGROUND
  • Grabsch EA, Mitchell DJ, Hooper J, Turnidge JD. In-use efficacy of a chlorhexidine in alcohol surgical rub: a comparative study. ANZ J Surg. 2004 Sep;74(9):769-72. doi: 10.1111/j.1445-1433.2004.03154.x.

    PMID: 15379808BACKGROUND
  • Nishimura C. Comparison of the antimicrobial efficacy of povidone-iodine, povidone-iodine-ethanol and chlorhexidine gluconate-ethanol surgical scrubs. Dermatology. 2006;212 Suppl 1:21-5. doi: 10.1159/000089195.

    PMID: 16490971BACKGROUND
  • Geelhoed GW, Sharpe K, Simon GL. A comparative study of surgical skin preparation methods. Surg Gynecol Obstet. 1983 Sep;157(3):265-8.

    PMID: 6612574BACKGROUND
  • Keblish DJ, Zurakowski D, Wilson MG, Chiodo CP. Preoperative skin preparation of the foot and ankle: bristles and alcohol are better. J Bone Joint Surg Am. 2005 May;87(5):986-92. doi: 10.2106/JBJS.D.02695.

    PMID: 15866960BACKGROUND

Related Links

MeSH Terms

Interventions

Povidone-Iodine

Intervention Hierarchy (Ancestors)

IodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Scott Sporer, MD

    Midwest Orthopaedics at Rush

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2010

First Posted

August 18, 2010

Study Start

November 1, 2009

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

April 16, 2013

Record last verified: 2013-04

Locations